Back
Mirum Pharmaceuticals Stock Price Chart
Sponsored
MIRM
Sponsored
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here
Sell
50
MIRM
Mirum Pharmaceuticals
Last Price:
$41.52
Seasonality Move:
2.34%
7 Day Trial
ALL ACCESS PASS
$
7
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MIRM is experiencing slight selling pressure.
Mirum Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 41.67 | Sell |
20-day SMA: | 43.2 | Sell |
50-day SMA: | 42.22 | Sell |
200-day SMA: | 35.33 | Buy |
8-day EMA: | 41.94 | Sell |
20-day EMA: | 42.53 | Sell |
50-day EMA: | 42.21 | Sell |
200-day EMA: | 37.25 | Buy |
Mirum Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.4 | Sell |
Relative Strength Index (14 RSI): | 43.8 | Sell |
Chaikin Money Flow: | -77531 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.81 - 45.25) | Sell |
Bollinger Bands (100): | (39.25 - 43.51) | Buy |
Mirum Pharmaceuticals Technical Analysis
Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Mirum Pharmaceuticals Stock
Is Mirum Pharmaceuticals Stock a Buy?
-
Mirum Pharmaceuticals share price is 41.56 while MIRM 8-day simple moving average is 41.67, which is a Sell signal.
-
The stock price of MIRM is 41.56 while Mirum Pharmaceuticals 20-day SMA is 43.20, which makes it a Sell.
-
Mirum Pharmaceuticals 50-day simple moving average is 42.22 while MIRM share price is 41.56, making it a Sell technically.
-
MIRM stock price is 41.56 and Mirum Pharmaceuticals 200-day simple moving average is 35.33, creating a Buy signal.
MIRM Technical Analysis vs Fundamental Analysis
Sell
50
Mirum Pharmaceuticals (MIRM)
is a Sell
Is Mirum Pharmaceuticals a Buy or a Sell?
-
Mirum Pharmaceuticals stock is rated a SellThe current Mirum Pharmaceuticals [MIRM] share price is $41.56. The Score for MIRM is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Mirum Pharmaceuticals Stock Info
Market Cap:
2B
Price in USD:
41.56
Share Volume:
215.7K
Mirum Pharmaceuticals 52-Week Range
52-Week High:
48.89
52-Week Low:
23.14
Sell
50
Mirum Pharmaceuticals (MIRM)
is a Sell
Mirum Pharmaceuticals Share Price Forecast
-
What is the Mirum Pharmaceuticals stock price today?The Mirum Pharmaceuticals stock price is 41.56 USD today.
-
Will MIRM stock go up or go down?Mirum Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Mirum Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Mirum Pharmaceuticals is overvalued.
Is Mirum Pharmaceuticals Stock a Buy?
-
Mirum Pharmaceuticals share price is 41.56 while MIRM 8-day exponential moving average is 41.94, which is a Sell signal.
-
The stock price of MIRM is 41.56 while Mirum Pharmaceuticals 20-day EMA is 42.53, which makes it a Sell.
-
Mirum Pharmaceuticals 50-day exponential moving average is 42.21 while MIRM share price is 41.56, making it a Sell technically.
-
MIRM stock price is 41.56 and Mirum Pharmaceuticals 200-day simple moving average is 37.25, creating a Buy signal.
Fundamental Analysis of Mirum Pharmaceuticals
Is Mirum Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.02 per share, and an increase next year of $0.80 per share.
Technical Analysis of Mirum Pharmaceuticals
Should I short Mirum Pharmaceuticals stock?
-
MIRM Moving Average Covergence Divergence (MACD) indicator is -0.4, suggesting Mirum Pharmaceuticals is a Sell
-
Mirum Pharmaceuticals Relative Strength Index (RSI) is 43.8, which suggest Mirum Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Mirum Pharmaceuticals is (41.81 - 45.25), which suggest Mirum Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Mirum Pharmaceuticals is (39.25 - 43.51), which suggest Mirum Pharmaceuticals is a Buy
* Mirum Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.